Amy M Yule1,2,3, Rachael M Lyons1, Timothy E Wilens1,2,3. 1. Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, MA 02114. 2. Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA 02114. 3. Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114.
Abstract
PURPOSE OF REVIEW: To review information specific to adolescents regarding trends in opioid use, risk factors for opioid misuse, medical co-morbidity, and treatment updates. RECENT FINDINGS: Although opioid misuse in adolescents is uncommon, it is associated with morbidity and mortality such as hepatitis C and overdose. Adolescents commonly start with prescription opioid misuse before transitioning to heroin use. The existing literature supports the use of buprenorphine/naloxone for the treatment of adolescent opioid use disorders. Safe medication storage and disposal is important to decrease adolescent prescription opioid misuse. SUMMARY: Opioid misuse occurs in adolescents and pediatric providers need to remain up to date.
PURPOSE OF REVIEW: To review information specific to adolescents regarding trends in opioid use, risk factors for opioid misuse, medical co-morbidity, and treatment updates. RECENT FINDINGS: Although opioid misuse in adolescents is uncommon, it is associated with morbidity and mortality such as hepatitis C and overdose. Adolescents commonly start with prescription opioid misuse before transitioning to heroin use. The existing literature supports the use of buprenorphine/naloxone for the treatment of adolescent opioid use disorders. Safe medication storage and disposal is important to decrease adolescent prescription opioid misuse. SUMMARY: Opioid misuse occurs in adolescents and pediatric providers need to remain up to date.
Entities:
Keywords:
adolescent; heroin; medication; opioid use disorder; prescription opioid misuse
Authors: Lisa A Marsch; Warren K Bickel; Gary J Badger; Marne E Stothart; Kimberly J Quesnel; Catherine Stanger; John Brooklyn Journal: Arch Gen Psychiatry Date: 2005-10
Authors: Lorna E Thorpe; Lawrence J Ouellet; Ronald Hershow; Susan L Bailey; Ian T Williams; John Williamson; Edgar R Monterroso; Richard S Garfein Journal: Am J Epidemiol Date: 2002-04-01 Impact factor: 4.897
Authors: Thomas Kerr; Nadia Fairbairn; Mark Tyndall; David Marsh; Kathy Li; Julio Montaner; Evan Wood Journal: Drug Alcohol Depend Date: 2006-09-07 Impact factor: 4.492
Authors: George E Woody; Sabrina A Poole; Geetha Subramaniam; Karen Dugosh; Michael Bogenschutz; Patrick Abbott; Ashwin Patkar; Mark Publicker; Karen McCain; Jennifer Sharpe Potter; Robert Forman; Victoria Vetter; Laura McNicholas; Jack Blaine; Kevin G Lynch; Paul Fudala Journal: JAMA Date: 2008-11-05 Impact factor: 56.272